Market Research Blog – Page 1154 – New Product Development

Global Atherosclerosis Market Projected to Reach USD 59,514.3 Million by 2033 at a 2.8% of CAGR

The global atherosclerosis treatments market is poised for steady growth, with an estimated valuation of USD 59,514.3 million by 2033, increasing from its current value of USD 45,165.6 million in 2023. This represents a compound annual growth rate (CAGR) of 2.8% over the forecast period from 2023 to 2033.

A significant driver of this growth is the rising prevalence of cardiovascular disorders worldwide, which is increasing the demand for effective treatments and therapies for atherosclerosis, a leading cause of heart disease. As the global burden of cardiovascular conditions continues to escalate, the atherosclerosis market is expected to witness sustained expansion over the next decade.

This growth highlights the critical need for advancements in treatment options and innovations within the healthcare sector aimed at addressing this widespread condition.

Crucial information and forecast statistics covered in the Atherosclerosis market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Atherosclerosis Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Atherosclerosis market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Atherosclerosis market.

Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Atherosclerosis market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

A Old Full Report Analysis Click Here

Atherosclerosis Market: Segmentation

Valuable information covered in the FMI’s Atherosclerosis market report has been segregated into key segments and sub-segments.

By Therapy

Medications
Cholesterol-lowering medications
Antiplatelet drugs and anticoagulants
Beta blockers
Diuretics, or water pills
Angiotensin converting enzyme (ace) inhibitors
Others

By Surgery

Bypass surgery (Coronary Artery Bypass Grafting (CABG))
Angioplasty
Atherectomy

Key players covered in the report include:

GlaxoSmithKline plc.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Isis Pharmaceuticals, Inc.
Anthera Pharmaceuticals
Novartis AG
Sanofi
Johnson and Johnson
Bayer AG
The Medicine Company
Cardium Therapeutics

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global 3D Printed Medical Implants Market Poised for Strong Growth USD 2,494.5 Million by 2032 at a 12.5% of CAGR

The global 3D printed medical implants market is expected to experience robust growth, with a projected compound annual growth rate (CAGR) of 12.5%, reaching an estimated value of USD 2,494.5 million by 2032. This expansion is being driven by an increasing prevalence of various medical conditions, fueling demand for advanced solutions such as 3D-printed dental bridges, crowns, acetabular hip implants, and shoulder implants.

In addition to the growing need for innovative implant solutions, ongoing collaborations between companies, hospitals, and rehabilitation centers to develop personalized medical devices are further accelerating market growth. These partnerships are enabling customized healthcare solutions that address the specific needs of individual patients.

Emerging markets are expected to offer lucrative business opportunities during the forecast period, contributing significantly to the market’s expansion. However, the growth trajectory may face some challenges, particularly due to the stringent approval process required for the introduction of new materials in 3D printed implants, which can slow down market entry.

Global 3D Printed Medical Implants Market: Dynamics

In recent years, the sales of craniomaxillofacial and dental implants have grown in numerous countries of developed regions. Growing demand for a range of patient-specific implants is boosting the 3D printed medical implants market. Researchers have been leveraging computer-aided design software to come out with new types of patient-specific artificial medical implants. The demand for safer and effective patient-specific treatments with 3D implants in the 3D printed medical implants market is the result of concerted efforts by physicians, manufacturers, and surgeons. Growing use of 3D printed medical implants in orthopedics is a key trend boosting the market. The advent of innovative design of implants help in reducing their stiffness and drive bone cell growth. Further, new opportunities have emerged on the back of user-friendly software.

Technological progress in the 3D printed medical implants market hinges increasingly on how well stakeholders navigate logistical and regulatory hurdles. Since the healthcare application of 3D printing is relatively recent, regulatory framework wields a marked impact on the evolution of the market. Further, these hurdles may impede fast commercialization of 3D printed medical implant in hospital settings.

Impact of COVID-19 on the Healthcare Industry

The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years.

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the 3D Medical Implants Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.

The team of analysts at Future Market Insights are focusing on research and market study to produce different 3D Medical Implants Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the 3D Medical Implants Market.

A Old Full Report Analysis Click Here

Key Segments Profiled In The 3D Printed Medical Implants Market Survey

By Material:

Metals
Ceramics
Polymers
Composites

By Application:

Hearing Aids
Dentistry
Orthopaedic
Others

By Region:

North America
Latin America
Asia Pacific
MEA
Europe

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Antiviral Drugs Market to Reach USD 89.68 Billion by 2033 at a 3.9% of CAGR

The global antiviral drugs market is poised for steady growth over the next decade, with an expected compound annual growth rate (CAGR) of 3.9% from 2023 to 2033. The market is projected to reach a valuation of USD 61.42 billion in 2023 and is anticipated to expand further, reaching approximately USD 89.68 billion by 2033.

The continued growth of the antiviral drugs market can be attributed to rising demand for effective treatments for viral infections, ongoing advancements in healthcare, and the development of novel antiviral therapies. The market is set to play a crucial role in combating various viral diseases, offering promising opportunities for pharmaceutical companies and healthcare providers.

The late stage pipeline drugs are expected to enter the market, which will positively impact the market. Most antivirals are considered comparatively harmless to host, and therefore are used to treat infections. They are different from viricides, which are not used for medication but can destroy or deactivate virus particles, either outside or inside the body.

The anti-viral drugs are used in the treatment of patients suffering from herpes viruses, HIV, influenza A and B viruses and the hepatitis B and C viruses.

Anti-viral Drugs Market: Drivers and Restraints

As of October 2013, according to WHO, there were around 35.3 Mn people globally, infected with HIV. Therefore, increased viral infection incidences is one of the important factors that drives the anti-viral drugs market growth. Because of the solid R&D activities, newer and advanced treatments and formulations, such as vaccines, combination therapy and others, are being introduced in the market.

Hence, strong R&D is one of the crucial factors in the anti-viral drugs market growth. On the other hand, high risk of failure, high cost of R&D and therapy, and government austerity are some of threats expected to hinder the growth of market.

These are some factors anticipated to fuel growth of global anti-viral drugs market within the forecast period of 2016-2026. However, increasing usage of natural products and high cost of developing drugs are the key challenges faced by the market.

Anti-viral Drugs Market: Overview

The generic market of anti-viral drugs is presently dominated by products such as didanosine, zidovudine, lamivudine and stavudine. The biggest driver of overall anti-viral drugs market is Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) therapeutic sales which accounted for more than half the share of the market 2010.

At the end of 2012, 9.7 million people in low-income and middle-income countries were on antiretroviral treatment (ART). According to WHO, in 2012, number of patients on ART increased by 1.6 Mn, the largest increase in one year.

Nearly four out of five people were freshly put on treatment in the sub-Saharan Africa. In 21 African countries with a high burden of HIV, two out of three people in need are receiving treatment, and two out of three positive pregnant women are receiving antiretroviral drugs to prevent HIV transmission to their infants.

Anti-viral Drugs Market: Regional Overview

Region wise, the global anti-viral drugs market is classified into regions namely, North America, Eastern Europe, Western Europe, Latin America, Japan, Asia-Pacific, Middle East and Africa. According to WHO, in countries with Major ART scale-up such as Brazil or China, the death rate among people living with HIV has decreased by 80%. In 2015, in India the number of people living with HIV were 2.1 Mn and in U.S. the number was around 1.2 Mn in the year 2013.

Anti-viral Drugs Market: Key Players

Some of the key players in global anti-viral drugs market, which are focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, include Roche, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott, AstraZeneca, Cipla, Schering-Plough, Johnson & Johnson, Merck & Co and others.

A Old Full Report Analysis Click Here

Key Segments Covered in the Anti-Viral Drugs Industry Analysis

Anti-Viral Drugs Market by Product type:

Hepatitis-C antivirals
HIV antivirals
Herpes antivirals
Hepatitis-B antivirals
Influenza antivirals
Others (Pneumonia, Flu, etc.)

Anti-Viral Drugs Market by End-user:

Hospitals
Clinics
Ambulatory Surgical Centers

Anti-Viral Drugs Market by Region:

North America Anti-Viral Drugs Market
Latin America Anti-Viral Drugs Market
Europe Anti-Viral Drugs Market
Asia Pacific Anti-Viral Drugs Market
The Middle East & Africa Anti-Viral Drugs Market

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Vestibular Testing System Market Expected to Grow to USD 202.4 Million by 2033 at a 5.4% of CAGR

The global vestibular testing system market is on track for substantial growth, with a projected valuation of USD 119.3 million in 2023. According to recent forecasts, the market is expected to reach approximately USD 202.4 million by 2033, reflecting a notable compound annual growth rate (CAGR) of 5.4% over the forecast period.

The anticipated growth in the vestibular testing system market is attributed to ongoing advancements in diagnostic technology and increasing demand for accurate and reliable tools for assessing balance disorders. Vestibular testing systems play a crucial role in diagnosing and managing conditions related to balance and dizziness, contributing to their rising market presence.

As the healthcare industry continues to focus on enhancing diagnostic capabilities, the vestibular testing system market is set to expand, offering improved solutions for patient care and clinical outcomes.

Vestibular testing systems are used to diagnose patients suffering from balance problems. However, many recent studies have analyzed that vestibular testing systems are more accurate than medical examination in identifying inner ear disorders.

Tests for hearing evaluations are categorized into audiometric hearing evaluation, videonystagmography (VNG), vestibular evoked myogenic potential (VEMP), rotary chair and computerized dynamic posturography. The tests include hearing evaluations because the balance and hearing functions of the inner ear are closely related.

The vestibular tests are suggested for those people who are mainly suffering from vertigo, balance disorders, disequilibrium, benign paroxysmal positional vertigo (BPPV) and concussion. The main objective of the vestibular testing system is to decrease the symptoms of vertigo & dizziness, improve gaze stability and decrease risk of falls.

According to the CDC, more than one third of adults of age 65 and older fall each year in the United States and about 20% to 30% of people who fall suffer moderate to severe injuries.

Vestibular Testing System Market: Drivers and Restraints

The factors responsible for the growth of global vestibular testing system are improving healthcare infrastructure and increased risk of clinically significant outcomes such as falls. In addition, rise in the prevalence of balance disorders is significantly expanding the scope of vestibular testing systems.

However, high cost of tests and lack of skilled professionals in understanding test results are some of the factors which arerestraining the growth of global vestibular testing system market.

Vestibular Testing System Market: Overview

Based on test type, the global vestibular testing system market is segmented into Videonystagmography (VNG), Vestibular evoked myogenic potential (VEMP), Rotary chair, Computerized dynamic posturography and others. Based on end user, the market is segmented into hospitals, diagnostic centers and clinics.

Hospitals are preferred more due to the supervision of the physicians and availability of comparatively better skilled professionals.

Vestibular Testing System Market: Regional Overview

Region wise, the global vestibular testing system market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. The market in North America is expected to hold the largest share due to new product innovations, lifestyle changes and early treatment adoption.

Europe is the second leading market for vestibular testing system due to development activities and large research base. The Asia Pacific market is also expected to show a significant growth rate over the forecast period. Overall, the global vestibular testing system market is expected to show significant growth over the forecast period.

Vestibular Testing System Market: Key Players

Some of the key players in the global vestibular testing system market are Balanceback, BeOn Solutions, DIFRA, BioMed Jena, Vesticon, Inc., Recorders & Medicare Systems, Happersberger otopront GmbH, Interacoustics, Homoth Medizinelektronik GmbH & Co., Ecleris S.R.L, MEDI-CARE SOLUTIONS srl, Micromedical Technologies, NAGASHIMA MEDICAL INSTRUMENTS.CO.,LTD., Natus Medical Incorporated, Otometrics A/S and TECHNO CONCEPT.

The report covers exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

A Old Full Report Analysis Click Here

Vestibular Testing System Market by Solution

By Test Type:

Videonystagmography (VNG)
Vestibular-evoked myogenic potential (VEMP)
Rotary chair
Computerized Dynamic Posturography
Others

By End User:

Hospitals
Diagnostic Centers
Clinics

By Region:

North America
Latin America
Europe
South Asia & Pacific
East Asia
The Middle East & Africa (MEA)

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

3D Printed Drugs Market Projected to Surge to USD 742.88 Million by 2032 at a 9.2% of CAGR

The global 3D printed drugs market is set for significant growth, with an estimated market value of USD 307.54 million in 2022. Projections indicate the market will reach approximately USD 742.88 million by 2032, reflecting a robust compound annual growth rate (CAGR) of 9.2% over the forecast period.

This growth is largely driven by the rising demand for personalized pharmaceuticals across various age groups. 3D printing technology enables the creation of customized drug formulations tailored to individual patient needs, enhancing treatment efficacy and patient satisfaction.

As advancements in 3D printing technology continue to evolve, the pharmaceutical industry is poised to benefit from increased flexibility and innovation in drug development and manufacturing. The expanding capabilities of 3D printing are expected to revolutionize how medications are produced and delivered, further fueling market expansion.

Quick solubility and customizable aspect of 3D printed drugs augments the demand for the same in the international market. These drugs are produced by the help of powder bed inkjet printing by adding the drug’s components in a layer by layer format- similar to 3D printing for any other application. This process of production makes the medications easier to swallow and is advantageous for people suffering from dysphagia.

Moreover, 3D printing has the potential to fasten up the arrival of customized pharmaceuticals or the development of therapeutic blends. With the help of 3D printing, medications could be personalized for each patient, which will likely be more effective than batch-produced medications as they would be produced individually with consideration for that patient’s medical history. All of these considerations aid the growth of the 3D printed drugs market during the forecast period.

“A surge in the demand for customized medications will fuel the global growth of the 3D printed drugs market over the forecast period,” says an FMI analyst.

Key Takeaways:

The inkjet printer technology segment will hold 24% of the 3D printed drugs market share by the end of 2022.
The hospitals and clinics end-user segment will own about 45% of the overall market share.
In 2022, the 3D printed drugs market in North America will account for 31.1% of the total market share.
Europe’s 3D drug printing market will hold 29.9% of the market share in 2022.
Immense potential for 3D printed drugs research will drive the Asia Pacific market to hold 27% of the overall market share in 2022.

Competitive Landscape:

Hewlett Packard Caribe, Merck, Cycle Pharmaceuticals, AstraZeneca, Aprecia, Osmotica Pharmaceuticals, Aprecia Pharmaceuticals LLC Extend Biosciences, Bioduro, Affinity Therapeutics, GlaxoSmithKline Plc, and FabRx Ltd. among others are some of the major players in the 3D printed drugs market profiled in the full version of the report.

Key market players are focusing on product development and new product launches to meet the growing demand. These organizations also employ strategic partnership and collaboration tactics to gain a competitive advantage.

More Insights into 3D Printed Drugs Market Report

In its latest report, FMI offers an unbiased analysis of the global 3D printed drugs market, providing historical data from 2017 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of the dosage form (3D printed tablets, 3D printed capsules, 3D printed multi drug implants, 3D printed nanoparticles, 3D printed solutions, other 3D printed drug dosage forms), technology (inkjet 3D printed drugs, direct write 3D printed drugs, zip dose 3D printed drugs, thermal inkjet 3D printed drugs, 3D printed drugs based on fuel deposition modeling, powder bed 3D printed drugs, stereo lithography (SLA) 3D printed drugs, semi solid extrusion (SSE) 3D printed drugs), and region.

According to the latest FMI reports, based on segmentation, the inkjet printer technology will gain momentum over the forecast period. This segment will likely account for 24% of the 3D printed drugs market share in 2022. Owing to technological advancement the inkjet printers are easier and convenient to use. In terms of end use, hospitals and clinics are expected to be major contributors to the overall growth of the target market As easy installation and fewer waste fasten up the manufacture of 3D printed drugs in hospitals and clinics, these end users are predicted to hold 45% of the overall market share.

Based on region, the 3D printed drugs market in North America will exhibit impressive growth during 2022-2032. Increasing incidences of chronic diseases, an aging population, access to a well-established healthcare infrastructure are some of the factors that drive the target market in this region. Thus, the 3D printed drugs market in North America will account for 31.1% of the total market share in 2022. Besides North America, Europe and the Asia Pacific regions, too, will register considerable 3D printed drugs market growth during the forecast period.

Key Companies Profiled

Hewlett Packard Caribe
Merck
Cycle Pharmaceuticals
AstraZeneca
Aprecia
Osmotica Pharmaceuticals
Aprecia Pharmaceuticals LLC
Extend Biosciences
Bioduro
Affinity Therapeutics
GlaxoSmithKline Plc
FabRx Ltd

A Old Full Report Analysis Click Here

Key Segments Covered in the 3D Printed Drugs Industry Analysis

3D Printed Drugs Market by Dosage Form:

3D Printed Tablets
3D Printed Capsules
3D Printed Multi Drug Implants
3D Printed Nanoparticles
3D Printed Solutions
Other 3D Printed Drug Dosage Forms

3D Printed Drugs Market by Technology:

Inkjet 3D Printed Drugs
Direct Write 3D Printed Drugs
Zip Dose 3D Printed Drugs
Thermal Inkjet 3D Printed Drugs
3D Printed Drugs based on Fused Deposition Modeling
Powder Bed 3D Printed Drugs
Stereo Lithography (SLA) 3D Printed Drugs
Semi Solid Extrusion (SSE) 3D Printed Drugs

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Polymer-Based Prefilled Syringe Market Poised for Strong Growth: Valuation to Hit USD 3.7 Billion by 2034 Amid Rising Demand for Biologics

The global polymer-based prefilled syringe market is on track for impressive growth, with sales forecasted to reach USD 3.7 billion by 2034. The market, valued at USD 2.3 billion in 2024, is expected to expand at a compound annual growth rate (CAGR) of 5.2% over the next decade. This surge is primarily fueled by the rising demand for biologics, a key factor driving the adoption of polymer-based syringes in the healthcare sector.

In 2023, the industry generated USD 2.1 billion in revenue and is projected to witness a significant year-on-year growth of 9.5% in 2024. The continued emphasis on biologic drugs, which require precise and safe delivery, is anticipated to further bolster the market.

Polymer-Based Prefilled Syringes: The Preferred Choice for Biologics Delivery

The growing prominence of biologics—a class of complex, large-molecule drugs—has transformed drug administration practices, emphasizing the need for safe and reliable delivery systems. Biologics are highly sensitive to environmental factors such as temperature, pH, and mechanical stress, which demand careful handling to maintain their stability and therapeutic efficacy.

Polymer-based prefilled syringes, made from materials like cyclic olefin copolymer (COC) and cyclic olefin polymer (COP), offer unique advantages over traditional glass syringes. Their inert nature ensures minimal interaction with biologic drugs, safeguarding the drug’s integrity throughout its shelf life. The low protein adsorption and absence of extractable substances in polymer syringes help prevent drug contamination, a critical requirement in biologic drug delivery.

Moreover, polymer syringes boast enhanced durability compared to glass, significantly reducing the risk of breakage during transportation and handling. This attribute is especially valuable in managing sensitive biologic drugs, contributing to reduced wastage and heightened patient safety.

Safety is a top priority in healthcare, and polymer-based prefilled syringes come with various safety features, such as needlestick prevention mechanisms and tamper-evident caps. The safety features reduce the risk of needlestick injuries and enhance patient compliance with self-administered medications, contributing to improved healthcare outcomes.

In the healthcare sector, patient safety and convenience take precedence. Polymer-based prefilled syringes equipped with safety features like needlestick prevention mechanisms and tamper-evident caps are gaining popularity among both healthcare providers and patients. These features not only mitigate the risk of needlestick injuries but also boost patient compliance with self-administered medications.

The trend towards home-based healthcare in North America, driven by the aging population’s increasing healthcare needs and the demand for more convenient solutions, aligns perfectly with the advantages of prefilled syringes. They empower patients to self-administer medications in the comfort of their homes, reducing the burden of frequent hospital visits and ultimately enhancing patient outcomes.

Growth Opportunities in the Polymer-based Prefilled Syringe Industry:

Increasing Demand for Biologics: The growing prevalence of chronic diseases and the rise in demand for biologic drugs are driving the adoption of polymer-based prefilled syringes, as they offer a reliable and convenient delivery system for biologics.
Advancements in Drug Delivery Technology: Ongoing advancements in polymer technology and drug delivery systems present opportunities for innovation in prefilled syringes, enhancing their performance, safety, and compatibility with a broader range of pharmaceutical formulations.
Rising Aging Population: The global aging population is contributing to a higher demand for self-administered drugs. Polymer-based prefilled syringes provide a user-friendly and safe option for elderly patients, leading to increased market growth.
Focus on Patient Convenience and Compliance: Pharma companies are increasingly recognizing the importance of patient-centric drug delivery. Polymer-based prefilled syringes offer ease of use, reducing the risk of dosage errors and improving patient compliance, thereby driving market growth.
Expansion in Emerging Markets: The expansion of pharmaceutical markets in emerging economies, coupled with the need for cost-effective and convenient drug delivery systems, creates significant growth opportunities for polymer-based prefilled syringes in these regions.

Industry Trends:

Rise of Biocompatible Polymers: The industry is witnessing a shift towards the use of biocompatible polymers, such as cyclic olefin polymers (COP) and cyclic olefin copolymers (COC), in prefilled syringe manufacturing. These materials offer improved compatibility with a wide range of drugs and reduce the risk of leachables and extractable.
Integration of Smart Technologies: Smart prefilled syringes with features like electronic injection control, connectivity, and dose tracking are emerging trends. These technologies enhance safety, provide real-time data, and improve overall patient management.
Sustainability and Environmental Concerns: The industry is increasingly focusing on sustainable practices and materials. This includes the development of eco-friendly polymer-based prefilled syringes and the implementation of recycling programs to reduce the environmental impact of disposable medical devices.
Customization and Personalization: There is a growing trend toward the customization of prefilled syringes to meet specific drug and patient requirements. This includes variable dose options, needle safety features, and the ability to accommodate high-viscosity drugs.
Regulatory Emphasis on Quality and Safety: Stringent regulatory standards and guidelines for drug delivery systems, including prefilled syringes, continue to shape industry trends. Manufacturers are investing in quality assurance and compliance to meet the evolving regulatory landscape and ensure patient safety.

Why Choose Future Market Insights

Serving domestic and international clients 24/7
Prompt and efficient customer service
Data collected from reliable primary and secondary sources
Highly trained and experienced team of research analysts
Seamless delivery of tailor-made market research reports

Key Companies Profiled

Ajinomoto Bio-Pharma, Inc.
Aptar Pharma (India) Pvt. Ltd.
Baxter International Inc.
Biocorp
Enable Injections, Inc.
Nipro Corp.
SHL Medical
Shandong Weigao Group
Stevanato Group
Unilife Corporation

Access Full Report: https://www.futuremarketinsights.com/reports/polymer-based-prefilled-syringe-market

Key Segments:

Application:

Anaphylaxis
Rheumatoid Arthritis
Diabetes
Others
- Vaccines and Other Biotech Drugs

End-Use

Hospitals
Mail Order Pharmacies
Ambulatory Surgery Centers

Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Fresh Produce Trays Market to Reach USD 232.6 Billion by 2033, Fueled by Focus on Food Waste Reduction and Sustainable Packaging Solutions

The global fresh produce trays market is expected to be valued at USD 142.8 billion in 2023, with a projected compound annual growth rate (CAGR) of 5.0% over the next decade, reaching approximately USD 232.6 billion by 2033. A significant driver of this growth is the increasing focus on reducing food waste and the adoption of sustainable packaging solutions.

Sustainable Packaging Takes Center Stage

As concerns about plastic pollution and climate change intensify, consumers and businesses are turning to eco-friendly packaging solutions. In the fresh produce trays market, recyclable materials like cardboard, paperboard, and molded pulp are gaining popularity. These materials are easily recyclable and reduce the environmental impact of packaging waste by limiting the amount of waste that ends up in landfills or the environment.

The use of recyclable trays helps retailers and consumers reduce the carbon footprint associated with packaging waste, offering a practical and sustainable solution that aligns with global environmental goals.

Biodegradable and Compostable Trays Address Plastic Waste

In addition to recyclable options, there is a growing demand for biodegradable and compostable fresh produce trays. These trays naturally decompose over time, leaving no harmful residues, and contribute to reducing the accumulation of plastic waste in landfills and oceans. Derived from renewable resources such as plant-based fibers or agricultural by-products, biodegradable trays offer an eco-friendly alternative to traditional plastic packaging while supporting sustainable farming practices.

The rise of online grocery shopping has also contributed to the growth of the fresh produce trays market. With more consumers turning to e-commerce platforms for their daily food needs, there is a growing demand for packaging solutions that can effectively protect and deliver fresh produce to the customer’s doorstep. Fresh produce trays play a vital role in this process by providing a protective and secure packaging solution, ensuring the safe transportation of perishable items like fruits and vegetables.

Sustainable Packaging Solutions Take Center Stage

Consumer and business concerns about environmental impact are driving a shift towards sustainable practices in the packaging industry. This is reflected in the fresh produce trays market with the rise of:

Recyclable Trays: Trays made from cardboard, paperboard, or molded pulp offer a lower environmental impact and can be easily recycled, reducing landfill waste.
Biodegradable & Compostable Options: These trays break down naturally over time, minimizing plastic pollution and often utilizing renewable resources like plant-based fibers.

Active Packaging Technologies Extend Freshness

Antimicrobial Coatings: These coatings inhibit harmful bacteria growth, promoting food safety and reducing spoilage.
Moisture Control Pads: Excess moisture is absorbed, preventing decay and maintaining crispness.
Ethylene Absorption: Certain materials capture ethylene gas, slowing down the ripening process and extending shelf life.

E-commerce Boom Drives Demand for Protective Packaging

The rise of online grocery shopping is creating a need for secure and effective packaging solutions for fresh produce:

Enhanced Protection: Fresh produce trays safeguard fruits and vegetables from damage during transportation.
Efficient Stacking & Nesting: This design optimizes space utilization, reducing transportation costs and environmental impact.

Regional Growth Prospects

North America: The US market is expected to see rapid growth due to high demand for fresh produce and the increasing popularity of online grocery shopping.
Asia: India and China, with their high consumption of seasonal fruits and vegetables, are projected to experience significant market expansion.
Europe: Similar growth trends are anticipated across European countries.

Looking Ahead: A Sustainable and Innovative Future

The fresh produce trays market presents a promising outlook. The convergence of sustainability concerns, innovative packaging technologies, and the e-commerce boom positions this market for continued growth. Market participants who prioritize eco-friendly solutions, functionality, and freshness preservation will be well-positioned to capitalize on this expanding market.

Access Full Report: https://www.futuremarketinsights.com/reports/fresh-produce-trays-market

Key Segments:

By Material:

Paper & Paperboard
Molded Fiber
Plastic
Foam

By Partition:

With Partition
Without Partition

By Distribution Channel:

Online
Offline

Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa (MEA)

Author

Ismail Sutaria (Lead Consultant, Packaging and Materials) has over 8 years of experience in market research and consulting in the packaging & materials industry. Ismail’s strength lies in identifying key challenges faced by the client and offering logical and actionable insights to equip the clients with strategic decision-making power.

Ismail has been an instrumental part of several transformational consulting assignments. His key skills include competitive benchmarking, opportunity assessment, macroeconomic analysis, and business transformation advisory. Ismail is an MBA holder in Marketing and has a Bachelor’s Degree in Mathematics.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Baobab Powder Market Set to Grow at a 6.2% CAGR by 2027, According to Future Market Insights Inc.

The global Baobab Powder Market is anticipated to witness robust growth during the assessment period. Future Market Insights studies the factors driving the popularity and adoption of baobab powder across the globe. Consumers today are becoming aware of the benefits of baobab powder, which in turn is surging the demand for baobab powder-based products such as cereals and bars.

Due to the fact that baobab powder has numerous skin benefits, it is used as an ingredient in various anti-aging creams and helps protect the skin against high or low temperatures, rejuvenates the skin cells, moisturizes the skin and prevents damage from free radicals. Also, as baobab powder is a rich source of calcium and potassium, it is also found in products such as cereals, bars, and jellies. Owing to its wide-ranging beneficial properties, the consumption of baobab powder is growing across the globe.

Segmental Forecast of the global baobab powder market

The global baobab powder is segmented on the basis of product type (organic baobab powder, conventional baobab powder), end use (industrial, retail), sales channel (direct sales, indirect sales) and region.

Forecast by Product Type: Organic baobab powder segment is expected to register the highest CAGR during the forecast period. The organic baobab powder segment is estimated to be valued at US$ 8,544.2 Mn by 2027 end and is expected to expand at a CAGR of 6.5% over the forecast period.

Forecast by End Use: The retail segment is estimated to account for the highest value share of 65.2% in 2017 and is projected to reach a market valuation of US$ 6,545.1 Mn by 2027 end, registering a CAGR of 6.3% over the forecast period.

Forecast by Sales Channel: The indirect segment is estimated to account for the highest value share of 75.4% in 2017. This segment is estimated to be valued at US$ 7,602.1 Mn by 2027 end and is expected to expand at a CAGR of 6.3% over the forecast period.

Forecast by Region: North America followed by Western Europe will be the leading markets in the global baobab powder market with an anticipated value share of about 30% and 25% respectively by the end of 2027. North America will witness the highest regional CAGR of 6.8% during the forecast period.

Competitive Landscape

The report profiles some of the top companies operating in the global baobab powder market including:

EcoProducts
Baobab Fruit Company Senegal
B’Ayoba (Pvt) Ltd
Organic Africa, Aduna Limited
Etude House
Woodland Foods
Powbab Inc
ATACORA
Halka B. Organics
Indigo Herbs LTD and Organic Burst UK Ltd.

Companies are focussing on addressing customer centric product demand by expanding their product portfolio and introducing a variety of products in the global market. Suppliers are entering into long-term contracts with baobab products manufacturers to avoid increase in product prices, and baobab manufacturers are also benefitting from these long-term contracts with suppliers as it helps them sustain their operations.

Extensive Market Research: Complete Report and Findings

Global Baobab Powder Market Forecast 2017-2027

Future Market Insights predicts the global baobab market to be valued at about US$ 5,483 Mn by the end of 2017 and will continue to grow at a CAGR of 6.2% during the period of study to reach a market valuation of about US$ 10,004 Mn by the end of the forecast period.

Competitive Landscape

The report profiles some of the top companies operating in the global baobab powder market including:

EcoProducts
Baobab Fruit Company Senegal
B’Ayoba (Pvt) Ltd
Organic Africa, Aduna Limited
Etude House
Woodland Foods
Powbab Inc
ATACORA
Halka B. Organics
Indigo Herbs LTD and Organic Burst UK Ltd.
Companies are focussing on addressing customer centric product demand by expanding their product portfolio and introducing a variety of products in the global market. Suppliers are entering into long-term contracts with baobab products manufacturers to avoid increase in product prices, and baobab manufacturers are also benefitting from these long-term contracts with suppliers as it helps them sustain their operations.

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Global Food Waste Management Market Poised to Exceed USD 121.8 Billion by 2033 with a 5.7% CAGR

The food waste management sector (Mercado de gestión de residuos alimentarios) is poised for significant growth, with an estimated market value of US$ 70.0 billion in 2023, projected to reach US$ 121.8 billion by 2033, marking a robust CAGR of 5.7% over the forecast period.As food waste continues to escalate, spurred by uneaten or leftover food, the demand for effective food waste management solutions is on the rise. Increased consumer awareness regarding food wastage, coupled with government initiatives, is driving the adoption of food waste management practices. Industries such as animal feed, fertilizer, and renewable energy are driving market expansion by repurposing food waste into valuable resources.

The proliferation of biofuels and fertilizers, as well as the production of urea for agricultural purposes, presents lucrative opportunities for market growth. Moreover, the surge in kitchen waste from local food vendors, hotels, and food service centers further propels the adoption of food waste management strategies. Factors such as population growth, environmental concerns, and food spoilage due to excess quantities further contribute to the growing demand for food waste management solutions.

Additionally, the increasing availability of imported food items and surplus untasted food are bolstering the market share of food waste management. Large corporations, engaged in food processing and service industries, generate substantial quantities of food waste daily, highlighting the critical need for effective management practices.

What Measure does Government take to Reduce Food Waste?

Around the world, numerous nations are actively tackling the issue of food waste through various initiatives. Food wastage poses a significant challenge with far-reaching impacts on the environment, society, and global economies. Consequently, it has become a focal point for many countries. Despite this attention, substantial quantities of food continue to be wasted, while others face food shortages.

Governments worldwide are taking proactive measures to address this issue, launching awareness campaigns and programs aimed at reducing food wastage. For instance, the U.K. government has introduced the Love Food Hate Waste initiative, while Denmark has implemented the Stop Wasting Food program in recent years. Additionally, the United Nations has prioritized raising awareness among individuals to minimize food wastage and support initiatives like the Zero Hunger Challenge Program.

Key Takeaways:

The food waste management market is expected to have a valuation of US$ 121.8 billion by 2033.
The global market is likely to register a CAGR of 5.7% during the forecast period.
The United States food waste management market is anticipated to register a CAGR of 5.9% through 2033.
With a CAGR of 6.1%, the United Kingdom market is significantly estimated to uplift during the forecast period.
China’s market is projected to register a CAGR of 7.8% over the forecast period.

Who is winning?

The market is fragmented in nature. The prominent players provide services to the customers by adopting advanced technology. Moreover, they are focused on innovating products to collect and recycle food waste. The manufacturers are using various technologies such as automated garbage pickups, enzyme-based food management systems, and sensor-based waste management.

Recent Developments in the Food Waste Management Market:

Prominent vendors are making innovative technologies to reduce food waste. They are adopting several methods to enhance the quality and extend the shelf-life of food during the forecast period. For example, top manufacturing companies adopt clean-label packaging to provide excellent food safety by reducing food wastage.

Gain full access to the Food Waste Management Industry report, featuring comprehensive Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives.

Food Waste Management Market by Category

By Service:

Prevention
Collection
Transfer
Recycling
Landfill

By Waste Type:

Food Production Waste
Agri Produce Waste
Poultry, Meat, and Seafood Waste
Food Processing Waste
Agri Produce Processing Waste
Poultry, Meat, and Seafood Processing Waste
Dairy Food Processing Waste
Other Food Processing Waste
Distribution & Supply Chain Waste
Retail Waste
Consumption Waste
Household Food Waste
Food Services, Hospitality, & Institutional Waste

By End User:

Animal Feed
Fertilizer
Renewable Energy & Biofuels
Others

By Region:

North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Sweetener Market Expansion: Projected to Achieve USD 16.9 Billion Milestone by 2034

The global sweetener market is anticipated to reach a valuation of USD 10.8 billion by 2024, with a projected CAGR of 3.8%, likely expanding to USD 16.9 billion by 2034.

Natural sweeteners, the second-largest product category, have a global market share of about 22%. During the projection period, this category is expected to increase market share.

The main global sweetener competitors are expanding their financial and geographic reach. Furthermore, because there aren’t many buyers and sellers, most organisations are focusing on cost-cutting strategies.

Sweeteners’ most prevalent application is in the food and beverage industry. This category accounts for roughly 70% of current revenue. The food and beverage industry will be the most important application segment during the course of the forecast. In terms of revenue, the market will be worth over US$ 157.7 billion by 2032. Demand for food and beverages is predicted to grow at a 3.8% CAGR between 2022 and 2032.

Dairy goods and drinks are the two biggest sub-segments in the food and beverage industry. Together, these two sub-segments represent 40% of total revenue.

Sweetener Market Trends

Growing disposable income is propelling the expansion of the confectionery, bakery, and dairy sectors, driving the sweetener market’s growth.
Consumers’ preference for clean-labeled products like low-calorie, sugar-free, and additive-free options is boosting the sweetener market.
Increased investment in research & development and supply chain analysis is expected to expand the global sweetener market.
Limited availability of expensive raw materials is likely to result in higher prices for natural and organic sweeteners.
Rising obesity rates among consumers are a significant growth factor for the organic and natural sweetener market.

North America Sweeteners Market

In North America and around the world, sucrose remains the most popular product category. In terms of sales, sucrose presently accounts for roughly 55% of the North American market. Sucrose demand in the North American sweetener market will continue to rise due to its use in the food and beverage industries. The food and beverage sector accounts for more than 71% of North America’s revenue, and it will remain crucial during the predicted period.

Increasing middle-class awareness in China and India is a key element driving rising demand for sweeteners in Asia Pacific excluding Japan. The APEJ sweetener industry is expected to grow steadily, creating new opportunities for manufacturers. Given the sheer volume and scale of demand in APEJ, several firms are attempting to consolidate their position in the market.

Key companies profiled in the report include Carl Kühne KG (GmbH & Co.), Castelo Alimentos S/A, Aspall Cyder Ltd, White house foods, Spectrum Organic Products, LLC, Higher Nature Limited., Vitane Pharmaceuticals, Inc., the kraft heinz company, Bragg Live Food Products, Inc., Swanson Health Products, Inc., Solana Gold Organics, Amfac, Inc.(American Garden), Mautner Markhof Feinkost GmbH, GNC holdings inc, Eden Foods, Inc., Pompeian, Inc., NutraMarks, Inc., Eden Nuganics, Viva Naturals, Health Connection Wholefoods.

Extensive Market Research: Complete Report and Findings

Sweetener Market: Segmentation

By Sweetener Type :

novel sweeteners
natural sweeteners
sugar alcohol
sucrose
artificial sweeteners

By Industry :

food & beverage (sweet spreads, bakery goods, beverages, dairy products, confectionery & chewing gums and others)
direct sales
pharmaceuticals
others.

By Region :

Eastern Europe
Japan
Middle-East & Africa (MEA)
Latin America
Asia-Pacific excluding Japan (APEJ)
Western Europe
North America

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube